90 results

• Byetta, Victoza and Januvia Lawsuits Over Pancreatic Cancer Mount in Reinstated Litigation

  June 8, 2018

  Austin Kirk

  A growing number of lawsuits over claims that Byetta, Victoza and similar diabetes drugs can cause pancreatic cancer are being filed in the wake of a recent decision to reinstate the litigation.

• Pancreatic Cancer Lawsuits Over Januvia, Byetta and Victoza Not Set For Bellwether Trials Until 2020

  March 28, 2018

  Irvin Jackson

  A new schedule for Byetta, Januvia and Victoza pancreatic cancer lawsuits sets the first bellwether trial for January 2020.

• Hundreds of Januvia, Victoza, Byetta Lawsuits Reinstated by Appeals Court Ruling

  December 14, 2017

  Austin Kirk

  More than 700 Victoza, Byetta, Januvia and Janumet pancreatic cancer lawsuits have been reinstated by a federal appeals court, overturning a summary judgment that led to their dismissal in 2015.

• Side Effects of Invokana, Similar Drugs, Double Risk of Diabetic Ketoacidosis: Study

  June 9, 2017

  Austin Kirk

  A new study highlights the diabetic ketoacidosis risk with Invokana, indicating that users of the new generation diabetes drug may be twice as likely to develop this dangerous build up of acid levels in the blood.

• Study Finds Little Difference Between Diabetes Drugs’ Effectiveness

  July 27, 2016

  Irvin Jackson

  The findings of a new study suggest that there is little difference between a variety of diabetes drugs currently on the market, despite a wide range of risks.

• Sulphonylureas Linked To Higher Risk of Hypoglycemia: Study

  July 26, 2016

  Russell Maas

  A popular class of diabetes drugs may be causing blood glucose levels to drop too low in some diabetics, resulting in an increased risk of hypoglycemic health problems, according to the findings of a new study.

• Onglyza, Januvia Not Linked To Increased Heart Failure Risk: Study

  June 10, 2016

  Irvin Jackson

  Two new studies find no evidence of heart failure risk associated with Onglyza and Januvia, contradicting some previous studies and an FDA warning.

• Problems Combining Onglyza, Januvia With Sulphonylureas May Increase Risk Of Low Blood Sugar: Study

  May 13, 2016

  Irvin Jackson

  Combining Januvia and Onglyza with certain other diabetes drugs could result in dangerously low blood glucose levels, according to the findings of a new study.

• Heart Risks with Onglyza, Januvia Questioned By New Study

  May 2, 2016

  Irvin Jackson

  A new study failed to find any link between Onglyza, Januvia and similar diabetes drugs and an increased risk of heart failure.

• Invokana Study Claims Superiority over Januvia, Despite Ketoacidosis, Kidney Injury Risks

  March 21, 2016

  Irvin Jackson

  A new study indicates that Invokana is more effective than Januvia at helping to meet blood glucose goals, but the drug is plagued with concerns over diabetic ketoacidosis and kidney damage.